<bill session="116" type="h" number="2455" updated="2022-02-08T23:19:36Z">
  <state datetime="2019-05-01">REFERRED</state>
  <status>
    <introduced datetime="2019-05-01"/>
  </status>
  <introduced datetime="2019-05-01"/>
  <titles>
    <title type="display">Ensuring Timely Access to Generics Act of 2019</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.</title>
    <title type="short" as="introduced">Ensuring Timely Access to Generics Act of 2019</title>
  </titles>
  <sponsor bioguide_id="J000302"/>
  <cosponsors>
    <cosponsor bioguide_id="B001308" joined="2019-05-01"/>
    <cosponsor bioguide_id="C001121" joined="2019-05-28"/>
    <cosponsor bioguide_id="F000466" joined="2019-06-05"/>
    <cosponsor bioguide_id="S001199" joined="2019-06-13"/>
    <cosponsor bioguide_id="W000823" joined="2019-05-28"/>
    <cosponsor bioguide_id="W000827" joined="2019-05-28"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-05-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-05-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="1169" relation="identical"/>
    <bill session="116" type="s" number="3384" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-12T19:05:33Z" status="Introduced in House">Ensuring Timely Access to Generics Act of 2019

This bill requires the Food and Drug Administration (FDA) to consider certain factors in determining whether a petition is submitted for the primary purpose of delaying the approval of a drug application.

The FDA must (1) publish a list of petitions that were submitted with an intent to delay, and (2) establish procedures to refer such petitions to the Federal Trade Commission.

The FDA may establish a timeline for submitting petitions.</summary>
</bill>
